Dried blood spots for erythropoietin analysis: Detection of micro‐doses, EPO c.577del variant and comparison with in‐competition matching urine samples
Drug Testing and Analysis · 2024
DOI: 10.1002/dta.3596 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Drug Testing and Analysis, 2024. Verfasst von Carmel E Heiland und 5 weiteren Autor:innen. Beteiligte Einrichtung: Stockholm Doping Control Laboratory, Clinical Pharmacology Department, Karolinska University Hospital, Stockholm, Sweden. Hauptthemen laut MEDLINE: Erythropoietin, Dried Blood Spot Testing, Doping in Sports, Substance Abuse Detection. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Karolinska Institutet, World Association of Anti-Doping Scientists (WAADS), FOU ME Clinical Pharmacology Karolinska University Hospital.
Abstract (Originalsprache)
The abuse of recombinant erythropoietin (rEPO) and other erythropoietin (EPO) receptor agonists (ERAs) in sports prompted the need for sensitive detection methods of these substances. Dried blood spot (DBS) samples offer an easy solution for simultaneous collection of blood and urine during a doping control, but sensitivity issues are often presented as a challenge for routine EPO analysis from DBS. Its potential use for detecting rEPO micro‐doses and the EPO gene c.577del variant thus needed further demonstration. Here, capillary blood collected from the arm skin of 111 athletes with Tasso‐M20 (17.5 μL/spot), collected during professional triathlon competitions, were analysed. Also, venous blood samples from healthy volunteers were used to prepare several spots of 20 μL on Mitra VAMS (from an rEPO micro‐dose study) and Whatman filter paper (from an EPO gene variant study). Immunopurification of 2 spots with MAIIA EPO Purification Gel Kit and analysis with sodium N‐lauroylsarcosinate polyacrylamide gel electrophoresis (SAR‐PAGE)/Western blot resulted in sensitive detection of (1) micro‐doses of rEPO from Mitra VAMS, (2) endogenous EPO from Tasso‐M20 in all in‐competition subjects, and (3) the EPO c.577del variant from Whatman filter paper. Additionally, in‐competition endogenous EPO was detected in DBS even when matching urine samples had undetectable EPO. In conclusion, this work demonstrated that DBS can be a useful complementary matrix to urine samples for EPO detection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Stockholm Doping Control Laboratory, Clinical Pharmacology Department, Karolinska University Hospital, Stockholm, Sweden.
- Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden.
- Laboratoire AntiDopage Français (LADF), Université Paris-Saclay, Orsay, France.
- Beijing Anti-Doping Laboratory, Beijing Sport University, Beijing, China.
ORCID-Profile: Xinmiao Zhou, Alexandre Marchand
Förderung
- Karolinska Institutet
- World Association of Anti-Doping Scientists (WAADS)
- FOU ME Clinical Pharmacology Karolinska University Hospital
- Partnership for Clean Competition
- Beijing Sport University
Zitieren
APA
Heiland, C. E., Martin, L., Zhou, X., Zhang, L., Ericsson, M., & Marchand, A. (2024). Dried blood spots for erythropoietin analysis: Detection of micro‐doses, EPO c.577del variant and comparison with in‐competition matching urine samples. Drug Testing and Analysis. https://doi.org/10.1002/dta.3596
Vancouver
Heiland CE, Martin L, Zhou X, Zhang L, Ericsson M, Marchand A. Dried blood spots for erythropoietin analysis: Detection of micro‐doses, EPO c.577del variant and comparison with in‐competition matching urine samples. Drug Testing and Analysis. 2024. doi:10.1002/dta.3596
BibTeX
@article{Heiland2024,
author = {Heiland, Carmel E and Martin, Laurent and Zhou, Xinmiao and Zhang, Lisi and Ericsson, Magnus and Marchand, Alexandre},
title = {Dried blood spots for erythropoietin analysis: Detection of micro‐doses, EPO c.577del variant and comparison with in‐competition matching urine samples},
journal = {Drug Testing and Analysis},
year = {2024},
doi = {10.1002/dta.3596}
}
EUVIMED